Endoscopic Mucosal Resection of a Sessile Polyp with Eleview™ скачать в хорошем качестве

Endoscopic Mucosal Resection of a Sessile Polyp with Eleview™

This overview of an endoscopic mucosal resection of a sessile polyp in the colon covers lesion identification, a submucosal injection with Eleview™, successful resection, and a view of the post-resection site. Intended use: Eleview™ submucosal injectable composition is intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancers, or other gastrointestinal mucosal lesions, prior to excision with a snare or endoscopic device. Aries Pharmaceuticals, Inc. is a wholly owned subsidiary of Aries Pharmaceuticals, Ltd., which is a wholly owned subsidiary of Cosmo Pharmaceuticals, NV, a specialty pharmaceutical company focused on developing and commercializing best-in-class products in endoscopy and treating gastrointestinal diseases. Aries is the US distributor of Cosmo Pharmaceutical products. Visit our About Page to learn more about Aries Pharmaceuticals, Inc. and Eleview:    / @ariespharmaceuticalsinc.5383   Subscribe to our channel to be updated when new videos are added. Let’s connect Aries Pharmaceuticals, Inc.: http://www.aries-pharma.com/ Eleview™: http://eleviewus.com/ Cosmo Pharmaceuticals: http://www.cosmopharmaceuticals.com/ LinkedIn:   / 1098.  . Twitter:   / cosmo_pharma   Important Safety Information Warnings and Precautions • The endoscopist injecting Eleview™ must be experienced in the administration technique. • The safety of Eleview™ has not been established in pregnant or lactating women, or in children under 18 years of age. Please see Eleview™ Instructions for Use for complete Important Safety Information at eleviewUS.com.